SAFC Opens HPAPI Facility

SAFC, a member of the Sigma-Aldrich Group, has opened a $30 million expansion to its Madison manufacturing facility in Verona, WI. The 51,000 sq.-ft. expansion increases capacity to produce commercial scale High Potency Active Pharmaceutical Ingredients (HPAPIs).

The new facility adds to the company’s existing 63,000 sq.-ft. HPAPI site in Madison and has commercial scale reactors capable of producing batch sizes as large as 4,000 liters. The facility was specifically constructed to support pharmaceutical manufacturers with Phase III and commercial HPAPI needs. The facility includes development labs, a 150L mini-processing plant and two large-scale cGMP manufacturing suites.

“With the High Potency market continuing to experience double-digit growth and ongoing significant advances in clinical pharmacology and oncology, there is a significant need for the large-scale production of HPAPIs,” said Gilles Cottier, SAFC president. “This new facility represents a significant step toward addressing that market demand and supports SAFC’s desire to maintain a leadership position in commercial scale High Potency manufacture.”